Pathological and Molecular Diagnosis of Uveal Melanoma

Mihai Adrian Păsărică,Paul Filip Curcă,Christiana Diana Maria Dragosloveanu,Alexandru Călin Grigorescu,Cosmin Ionuț Nisipașu

DOI: https://doi.org/10.3390/diagnostics14090958

IF: 3.6

2024-05-03

Diagnostics

Abstract:(1) Background: Uveal melanoma (UM) is a common malignant intraocular tumor that presents with significant genetic differences to cutaneous melanoma and has a high genetic burden in terms of prognosis. (2) Methods: A systematic literature search of several repositories on uveal melanoma diagnosis, prognosis, molecular analysis, and treatment was conducted. (3) Results: Recent genetic understanding of oncogene-initiation mutations in GNAQ, GNA11, PLCB4, and CYSLTR2 and secondary progression drivers of BAP1 inactivation and SF3B1 and EIF1AX mutations offers an appealing explanation to the high prognostic impact of adding genetic profiling to clinical UM classification. Genetic information could help better explain peculiarities in uveal melanoma, such as the low long-term survival despite effective primary tumor treatment, the overwhelming propensity to metastasize to the liver, and possibly therapeutic behaviors. (4) Conclusions: Understanding of uveal melanoma has improved step-by-step from histopathology to clinical classification to more recent genetic understanding of oncogenic initiation and progression.

medicine, general & internal

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve the understanding of the pathology and molecular diagnosis of uveal melanoma (UM). Specifically, the paper focuses on the following aspects:

1. **Pathological diagnosis**:
- Describe the histological features of uveal melanoma, including the cell types of the main tumor (such as epithelioid cells and spindle cells) and their tissue structures.
- Introduce different pathological classification systems, such as the Callender GR classification and the Armed Forces Institute of Pathology (AFIP) classification, and discuss the clinical significance of these classification systems.
- Verify the clinical effect of the American Joint Committee on Cancer (AJCC) TNM staging system, especially the relationship between tumor size (T) and stage (S) and the metastasis rate and survival rate.

2. **Molecular diagnosis**:
- Explore the importance of genetic analysis in uveal melanoma, especially its application in predicting the risk of metastasis and prognosis.
- Summarize the influence of genetic variations on chromosomes 3 and 8 (such as monosomy 3, 8q gain) on prognosis in multiple studies.
- Introduce The Cancer Genome Atlas (TCGA) classification system and verify its accuracy in predicting the risk of metastasis.

Through these studies, the paper aims to provide more comprehensive methods for the diagnosis and prognosis of uveal melanoma, thereby improving the treatment effect and survival rate of patients.